Purchase of 31,250 shares at $0.163 per share.
Reporting Person Equels Thomas K · Officer Title CEO & President · Transaction Code P
Traded Oct 22, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001493152-26-048196 · filed 2026-10-23 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "AIM ImmunoTech Inc. (AIM)." Disclosed 2026-10-23. https://desqlong.com/cards/0001493152-26-048196-1 (retrieved 2026-10-24).